1. Home
  2. All News

Category: Pharma and Healthcare

Next Year to Bring New Ways for New Deals

Despite the ongoing economic uncertainty from the pandemic, many private equity professionals are optimistic about the outlook for 2021 and are looking to alternative merger and acquisition methods to navigate the crisis and pursue new

Cotton Creek Capital Captures ConeCraft

Cotton Creek Capital has acquired ConeCraft, a maker of equipment used in the pharmaceutical and biopharmaceutical industries. ConeCraft specializes in manufacturing stainless steel bins, mixers, bioreactors, and tube management systems that are used for research

Kohlberg to Acquire Parts Authority

Kohlberg & Company has agreed to acquire a majority interest in Parts Authority, a distributor of automotive aftermarket parts, from The Jordan Company. Parts Authority (PA) is a distributor of nearly 500,000 SKUs of automotive

New Mountain Closes Sale of Specialty Chemical Maker

New Mountain Capital has sold Gelest to Mitsubishi Chemical America, the U.S. subsidiary of Mitsubishi Chemical. Gelest is a maker of specialized organo-silicon compounds, metal-organic compounds, and silicone materials that are used in both commercial

Blackstone backs skincare brand ZO Skin Health through Tactical Opportunities arm

Global private equity giant Blackstone has bought into skincare brand ZO Skin Health through its opportunistic Tactical Opportunities arm.

SK Carves-Out Specialty Polymers Biz of Baker Hughes

SK Capital has formed NuCera Solutions to acquire the specialty polymers business of Baker Hughes. NuCera produces specialty olefin polymers and high melting point polyethylene waxes that are used in adhesives, candles, coatings, imaging, personal

Aksia's COC Farmaceutici buys Tubilux

Aksia-backed drug manufacturer COC Farmaceutici has acquired Tubilux Pharma, an Italian pharmaceutical company specialising in ophthalmology.

KKR Sees “The New Normal”

KKR has released a new report titled “The New Normal” which explores the long-term implications of COVID-19 on cities and consumer trends. “Following a decade of relative prosperity, overlapping calamities in 2020 have brought economic

Windjammer Exits AI at 24x

Windjammer Capital has agreed to sell Advanced Instruments to Patricia Industries, a subsidiary of industrial holding company Investor AB, at an enterprise value of $780 million. Windjammer acquired Advanced Instruments from its founding family in

Arsenal Capital Partners brings in life sciences veteran Richard Eglen as senior advisor

Arsenal Capital Partners has named life sciences veteran Dr Richard Eglen as a senior advisor to its healthcare team.

Pamlico Buys ISAAC Instruments

Pamlico Capital has acquired ISAAC Instruments in partnership with the company’s founders. ISAAC Instruments designs and manufactures automated telemetry and video equipment that is used by truck fleets to monitor both drivers and trucks to

Peak Rock Still Hungry

Peak Rock Capital has acquired Halo Foods, a manufacturer of bars and snacks, in partnership with the company’s management team. Halo was acquired from Nimbus, a Dutch private equity firm. Halo’s products include cereal bars,

Permira acquires German group in biggest European pharma deal of 2020

Apax Partners has sold a controlling stake in Neuraxpharm. The deal that values the company at over €1.6bn, a person said

Apax sells Neuraxpharm to Permira

London-headquartered Apax Partners has sold its majority stake in Germany-based central nervous system (CNS) pharmaceutical products producer Neuraxpharm in an SBO to Permira.

Apax Partners to seal 3.5x return selling Neuraxpharma to Permira – sources

Apax Partners is set for a 3.5x return selling its stake in European pharma company Neuraxpharm to fellow private equity major Permira, AltAssets has learned.

Finance workers rush to get private Covid-19 tests as second wave looms

London finance workers are spending hundreds of pounds on Covid-19 tests offered by private doctors across the Square Mile

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.